Compare AbbVie Inc (ABBV) vs Walmart Stores Inc (WMT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs Walmart Stores Inc — how do they compare? AbbVie Inc trades at $253.81 (market cap $449.91B), while Walmart Stores Inc trades at $112.88 (market cap $887.64B). The key difference: Walmart Stores Inc is the larger of the two by market cap, and AbbVie Inc pays the higher dividend (2.72%). Which is the better fit depends on your goals.
| ABBV | WMT | |
|---|---|---|
Market Cap | $449.91B | $887.64B |
Sector | Health | Consumer Staples |
52-Week High | $261.07 | $134.20 |
52-Week Low | $184.85 | $94.40 |
Enterprise Value | $513.38B | $951.09B |
Dividend Yield | 2.72% | 0.89% |
Volume | — | 5,675,288 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $252.92, down 0.72% on the day, with strong technical support at $251 and resistance at $258. The stock shows bullish momentum with recent earnings beats and a consensus analyst price target of $266.33. Revenue grew to $61.16B in 2025, though net margins compressed to 5.79%. Key growth drivers include Skyrizi and Rinvoq offsetting Humira declines, supported by positive Phase 2 data for ELAHERE in ovarian cancer (PRNewsWire, 2026-04-12).
Outlook remains positive with immunology portfolio strength and dividend growth, but risks include patent cliffs in the 2030s and high debt levels. Institutional buying and 68% analyst buy ratings suggest confidence, though valuation multiples like P/E of 124.83 warrant caution. Near-term catalysts include Q2 2026 earnings expected at $3.79 EPS.
Walmart's stock trades at $110.65, down 1.06% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported strong revenue growth to $681.0B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent news highlights Walmart's AI initiatives and expansion of drone deliveries, while analyst consensus remains strongly bullish with a $141.64 price target.
The outlook is positive given Walmart's consistent earnings beats and strategic investments in technology, though near-term price pressure and competitive threats from Amazon pose risks. The stock offers a compelling entry point for long-term investors seeking defensive exposure with growth potential, supported by solid fundamentals and institutional confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Walmart Stores Inc
Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.
Read more on WMT →
